ResMed Unusual Options Activity For April 17 - ResMed (NYSE:RMD)

Whales with a lot of money to spend have taken a noticeably bullish stance on ResMed.

Looking at options history for ResMed (NYSE:RMD) we detected 10 trades.

If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with bullish expectations and 40% with bearish.

From the overall spotted trades, 6 are puts, for a total amount of $316,230 and 4, calls, for a total amount of $287,536.

Predicted Price Range

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $170.0 to $195.0 for ResMed over the last 3 months.

Insights into Volume & Open Interest

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for ResMed's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of ResMed's whale trades within a strike price range from $170.0 to $195.0 in the last 30 days.

ResMed Option Activity Analysis: Last 30 Days

Noteworthy Options Activity:

Symbol	PUT/CALL	Trade Type	Sentiment	Exp. Date	Ask	Bid	Price	Strike Price	Total Trade Price	Open Interest	Volume
RMD	PUT	SWEEP	BULLISH	05/17/24	$8.5	$6.2	$6.2	$175.00	$112.8K	812	192
RMD	CALL	TRADE	NEUTRAL	05/17/24	$11.0	$8.3	$9.8	$175.00	$98.0K	34	200
RMD	PUT	SWEEP	BULLISH	05/17/24	$4.2	$3.8	$4.1	$170.00	$79.9K	396	111
RMD	CALL	SWEEP	BEARISH	07/19/24	$9.4	$7.5	$7.5	$195.00	$72.8K	65	0
RMD	CALL	TRADE	BULLISH	05/17/24	$11.2	$8.9	$10.3	$175.00	$61.8K	34	0

About ResMed

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Following our analysis of the options activities associated with ResMed, we pivot to a closer look at the company's own performance.

ResMed's Current Market Status

With a volume of 211,966, the price of RMD is down -3.27% at $178.82.
RSI indicators hint that the underlying stock may be approaching oversold.
Next earnings are expected to be released in 8 days.

Professional Analyst Ratings for ResMed

Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $219.5.

Consistent in their evaluation, an analyst from Mizuho keeps a Buy rating on ResMed with a target price of $215.
An analyst from Needham has decided to maintain their Buy rating on ResMed, which currently sits at a price target of $224.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for ResMed with Benzinga Pro for real-time alerts.

RMDResMed Inc

$192.74-%

Overview

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.